Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Supernus Pharmaceuticals, Inc.

< Previous 1 2 Next >
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces Third Quarter 2023 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Participate in the Jefferies London Healthcare Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Participate in the Wells Fargo Healthcare Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Bethany L. Sensenig Joins Supernus’ Board of Directors
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces Second Quarter 2023 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Participate in the Jefferies Healthcare Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces First Quarter 2023 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Present at the Bank of America 2023 Health Care Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces Repayment of Convertible Notes
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Participate in Two Upcoming Investor Conferences
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Present at the Cowen 43rd Annual Health Care Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Enters Into $150 Million Credit Facility
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus to Present at Two November Healthcare Conferences
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Announces Third Quarter 2022 Financial Results
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
Supernus Provides Regulatory Update on SPN-830
From Supernus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SUPN
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.